PHALADEL
Board
1 director, last change in 2023Director, permanent representative Virginie VANDER CASSYEN
since 30-06-2023
6-year term from 2023
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 02-07-2026
1 other company struck offPermanent representatives 1
Virginie VANDER CASSYEN
Permanent representative, for PHARMACIE BLONDEAU - VANDER CASSYEN
appointed by deed of 20-07-2023
Mandates through the years
4 names, the dashed line is todayBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- PHARMACIE BLONDEAU - VANDER CASSYEN
- Director, from 30-06-2023 to date
- Anne DELTENRE
- Director, from before 28-07-2020 to 20-07-2023
- Guy DELTENRE
- Managing director and chair of the board, from before 28-07-2020 to 20-07-2023
- Managing director and chair of the board, from before 28-07-2020, ended, last mentioned on 28-07-2020
- Nicole DEVOLDRE
- Director, from before 28-07-2020 to 20-07-2023
Control
Parent
Equity €1.3m
Profit €156,603 in 2025 (profit €837,356 in 2024)
Checked score 89
100%
This company
PHALADEL
Equity €437,036
Profit €2,481 in 2025
Capital
- Capital
- €62,000
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- PHARMACIE BLONDEAU - VANDER CASSYEN
Source: lists of holdings in the owners' accounts
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off1 other company of this director was struck off by the FPS Economy (2023).
- PHARMACIE PHARMAVIE LE ROEULX struck off on 22-12-2023Official Gazetteappointed in 2020, still in office
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.